Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Helplifes Technology, widely known as WuXi STA, is a leading global Contract Development and Manufacturing Organization (CDMO) and a subsidiary of WuXi AppTec. The company provides integrated end-to-end solutions for small molecule pharmaceutical development and manufacturing, spanning from preclinical development to commercial supply. Its capabilities include process chemistry, formulation development, and the manufacturing of drug substances and drug products across various modalities such as oligonucleotides, peptides, and antibody-drug conjugates. With a global network of R&D and manufacturing sites, WuXi STA supports many of the world's leading pharmaceutical and biotech companies in accelerating their drug development timelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Helplifes Technology.